Ablation versus medication as initial therapy for paroxysmal atrial fibrillation: An updated meta‐analysis of randomized controlled trials
Abstract Background Recent randomized controlled trials (RCTs) suggest that ablation is superior to antiarrhythmic drugs (AADs) as an initial therapy for paroxysmal atrial fibrillation (pAF) to prevent arrhythmia recurrences. We performed an updated meta‐analysis of RCTs, to include recent data from...
Guardado en:
Autores principales: | Jakrin Kewcharoen, Narut Prasitlumkum, Ronpichai Chokesuwattanaskul, Ruiyang Yi, Krit Jongnarangsin, Thomas J. Bunch, Ravi Ranjan, Leenhapong Navaravong |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/131671c1fb6c4000ab19cf8b95454ef3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Predictors of Atrial Fibrillation Recurrences after a First Radiofrequency Catheter Ablation Intervention for Paroxysmal Atrial Fibrillation—Experience of a Low Volume Ablation Centre
por: Lavinia-Lucia Matei, et al.
Publicado: (2021) -
Cryoballoon Ablation Strategy in Persistent Atrial Fibrillation
por: Florian Straube, et al.
Publicado: (2021) -
Efficiency and safety of using the modified protocol for the administration of the domestic class III antiarrhythmic drug for the relief of paroxysmal atrial fibrillation
por: Khava M. Dzaurova, et al.
Publicado: (2021) -
Cryoballoon ablation of the left atrial posterior wall reduces recurrence of persistent atrial fibrillation in patients with non‐paroxysmal atrial fibrillation
por: Takatoshi Shigeta, et al.
Publicado: (2021) -
Study on the mechanism of Renshen Gansong herb in the treatment of paroxysmal atrial fibrillation based on network pharmacology
por: Jing-Qi Guo, et al.
Publicado: (2021)